{"organizations": [], "uuid": "afafee44a42127ccfc6d80a3dbc677d974946bb0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-cascadian-therapeutics-receives-pe/brief-cascadian-therapeutics-receives-pediatric-investigation-plan-waiver-from-the-european-medicines-agency-idUSFWN1OX07Z", "country": "US", "domain_rank": 408, "title": "BRIEF-Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver From The European Medicines Agency", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-02T15:37:00.000+02:00", "replies_count": 0, "uuid": "afafee44a42127ccfc6d80a3dbc677d974946bb0"}, "author": "", "url": "https://www.reuters.com/article/brief-cascadian-therapeutics-receives-pe/brief-cascadian-therapeutics-receives-pediatric-investigation-plan-waiver-from-the-european-medicines-agency-idUSFWN1OX07Z", "ord_in_thread": 0, "title": "BRIEF-Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver From The European Medicines Agency", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "european medicines agency", "sentiment": "negative"}, {"name": "european medicines agency reuters staff", "sentiment": "none"}, {"name": "cascadian therapeutics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 2, 2018 / 1:39 PM / Updated 26 minutes ago BRIEF-Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver From The European Medicines Agency Reuters Staff 1 Min Read \nJan 2 (Reuters) - Cascadian Therapeutics Inc: \n* CASCADIAN THERAPEUTICS RECEIVES PEDIATRIC INVESTIGATION PLAN WAIVER FROM THE EUROPEAN MEDICINES AGENCY Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)", "external_links": [], "published": "2018-01-02T15:37:00.000+02:00", "crawled": "2018-01-02T16:12:15.017+02:00", "highlightTitle": ""}